Rafi, et al. informed that lycopene attenuates PCa by modulating the expression of growth and survival associated genes, e.g. CDK7, BCL2, EGFR, and IGF-1R [58]; in addition, lycopene can inhibit PCa cell proliferation via PPARγ-LXRα-ABCA1 pathway [59]; Further, Zu, et al. [60] found that dietary intake of lycopene is associated with reduced risk of lethal PCa and with a lesser degree of angiogenesis in the tumor. Here, NR1H3 is linked to neoplasm.